Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 May-Jun;41(3):316-22.
doi: 10.3928/15428877-20100430-04.

Atorvastatin for diabetic macular edema in patients with diabetes mellitus and elevated serum cholesterol

Theonitsa D Panagiotoglou  1 , Emmanuel S Ganotakis, George D Kymionis, Joanna A Moschandreas, Garufalia N Fanti, Spyridon K Charisis, Niki E Malliaraki, Miltiadis K Tsilimbaris
Affiliations
Clinical Trial

Atorvastatin for diabetic macular edema in patients with diabetes mellitus and elevated serum cholesterol

Theonitsa D Panagiotoglou et al. Ophthalmic Surg Lasers Imaging. 2010 May-Jun.

Abstract

Background and objective: To determine the efficacy of atorvastatin in reducing hard exudates and diabetic macular edema.

Patients and methods: An uncontrolled clinical case series included 18 eyes with diabetic maculopathy and an elevated baseline lipid profile. All patients were treated with atorvastatin. Ophthalmologic evaluation, including fundus photography and fluorescein angiography, was performed at presentation and repeated at 3, 6, and 12 months. Hard exudates, hemorrhages, and fluorescein leakage at 12 months were evaluated and compared with baseline findings.

Results: Eighteen subjects with diabetic maculopathy received atorvastatin, and a significant decrease in total cholesterol and low-density lipoprotein cholesterol was seen (P < .05). Hard exudates and fluorescein leakage were decreased. No evidence of an association between change in hemorrhage status and treatment was found.

Conclusion: Oral atorvastatin therapy in patients with diabetes mellitus and dyslipidemia seems to reduce the severity of hard exudates and fluorescein leakage in diabetic maculopathy and could be useful as an adjuvant therapy in the management of diabetic macular edema.

PubMed Disclaimer

MeSH terms